William E. Rote Travere Therapeutics, Inc. (TVTX) insider trading activity

William E. Rote is SENIOR VICE PRESIDENT, R&D of Travere Therapeutics, Inc.. Currently has a direct ownership of 84,455 shares of TVTX, which is worth approximately $1.6 Million. The most recent transaction as insider was on Feb 03, 2021, when has been sold 3,625 shares (Common Stock) at a price of $28.91 per share, resulting in proceeds of $104,799. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 84.5K

0% 3M change

38.06% 12M change

Total Value Held $1.6 Million

WILLIAM E. ROTE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 03 2021	SELL Open market or private sale	$104,799 $28.91 p/Share	3,625 Reduced 8.85%	37,332 Common Stock
Feb 03 2021	BUY Grant, award, or other acquisition	-	4,500 Added 9.71%	41,832 Common Stock
Feb 02 2021	SELL Open market or private sale	$111,469 $30.75 p/Share	3,625 Reduced 7.7%	43,457 Common Stock
Jan 31 2021	BUY Grant, award, or other acquisition	-	5,000 Added 10.08%	44,582 Common Stock
Jan 21 2021	BUY Grant, award, or other acquisition	-	15,000 Added 27.48%	39,582 Common Stock
Nov 16 2020	SELL Open market or private sale	$59,900 $23.96 p/Share	2,500 Reduced 9.4%	24,086 Common Stock
Nov 13 2020	SELL Open market or private sale	$59,050 $23.62 p/Share	2,500 Reduced 8.6%	26,586 Common Stock
Nov 11 2020	BUY Grant, award, or other acquisition	-	5,000 Added 14.67%	29,086 Common Stock

WER

William E. Rote

SENIOR VICE PRESIDENT, R&D

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TVTX shares.

Notify only if

Value

Insider Trading

Get notified when an Travere Therapeutics, Inc. insider buys or sells TVTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Travere Therapeutics, Inc.

Track Activities on TVTX

Account